Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer
- 1 April 1996
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 27 (3) , 551-556
- https://doi.org/10.1016/0306-3623(95)02060-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of Levosimendan, a Cardiotonic Agent Targeted to Troponin C, on Cardiac Function and on Phosphorylation and Ca 2+ Sensitivity of Cardiac Myofibrils and Sarcoplasmic Reticulum in Guinea Pig HeartCirculation Research, 1995
- Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteersClinical Pharmacology & Therapeutics, 1994
- Medical advances in the treatment of congestive heart failure.Circulation, 1993
- Ionic basis for OPC-8212-induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytesEuropean Journal of Pharmacology, 1993
- Levosimendan increases calcium sensitivity without enhancing myosin ATPase activity and impairing relaxationJournal of Molecular and Cellular Cardiology, 1992
- Direct measurement of L-type Ca2+ window current in heart cells.Circulation Research, 1992
- ?Run-down? of the Ca current during long whole-cell recordings in guinea pig heart cells: role of phosphorylation and intracellular calciumPflügers Archiv - European Journal of Physiology, 1988
- The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparationsEuropean Journal of Pharmacology, 1985
- The steady state TTX-sensitive (?window?) sodium current in cardiac Purkinje fibresPflügers Archiv - European Journal of Physiology, 1979
- The effect of the duration of the action potential on contraction in the mammalian heart musclePflügers Archiv - European Journal of Physiology, 1968